Provention Bio Overview

  • Founded
  • 2016
Founded
  • Status
  • Public
  • Employees
  • 59
Employees
  • Stock Symbol
  • PRVB
Stock Symbol
  • Share Price
  • $8.37
  • (As of Friday Closing)

Provention Bio General Information

Description

Provention Bio Inc is a clinical-stage biopharmaceutical company. It is engaged in sourcing, developing, and commercializing novel therapeutics and cutting-edge solutions to intercept and prevent immune-mediated disease, including oncological, autoimmune, and inflammatory diseases. The company's product candidates include PRV-031, for the interception, delay, or prevention of type 1 diabetes; PRV-3279, for the potential treatment of systemic lupus erythematosus; and PRV-6527, PRV-300, and PRV-101.

Contact Information

Formerly Known As
Provention
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • P.O. Box 666
  • Oldwick, NJ 08858
  • United States
+1 (212) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Provention Bio Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$8.37 $8.47 $6.14 - $20.05 $530M 63.4M 2.74M -$2.11

Provention Bio Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 544,009 809,747 614,724 1,815
Revenue 0 0 0 0
EBITDA (119,290) (99,654) (44,372) (27,334)
Net Income (118,439) (98,581) (43,285) (26,478)
Total Assets 213,786 128,519 85,996 61,529
Total Debt 686 715 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Provention Bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Provention Bio‘s full profile, request access.

Request a free trial

Provention Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Provention Bio‘s full profile, request access.

Request a free trial

Provention Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provention Bio Inc is a clinical-stage biopharmaceutical company. It is engaged in sourcing, developing, and commerciali
Biotechnology
Oldwick, NJ
59 As of 2020
000.00
0000 0000-00-00
00000000 000.00

00000000

magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex
000000000000000
Mountain View, CA
000 As of 0000
00000
000000 - 000 00000

00000000

n reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occae
000000000000000
Tokyo, Japan
0 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Provention Bio Competitors (31)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Chemocentryx Formerly VC-backed Mountain View, CA 000 00000 000000 - 000 00000
000000000000 00000 Venture Capital-Backed Tokyo, Japan 0 000.00 0000000000 0 000.00
0000000 0000000000 Venture Capital-Backed Indianapolis, IN 0 000.00 0000000000 0 000.00
00000000 000000000 Formerly VC-backed Boston, MA 00 00000 000000000 00000
00000000000 Venture Capital-Backed San Diego, CA 00 000.00 00000000000 000.00
You’re viewing 5 of 31 competitors. Get the full list »

Provention Bio Executive Team (7)

Name Title Board Seat Contact Info
Ashleigh Palmer Chief Executive Officer & Founder
Andrew Drechsler Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Heidy King-Jones Chief Legal Officer, Legal
Francisco Leon MD Chief Scientific Officer & Founder
Jason Hoitt Executive
You’re viewing 5 of 7 executive team members. Get the full list »

Provention Bio Board Members (8)

Name Representing Role Since
Anthony DiGiandomenico MDB Capital Group Board Member 000 0000
Avery Catlin Provention Bio Board Member 000 0000
Jeffrey Bluestone Ph.D Self Board Member 000 0000
John Jenkins Provention Bio Board Member 000 0000
Nancy Wysenski Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Provention Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Provention Bio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Provention Bio‘s full profile, request access.

Request a free trial